Scarica l'app Stockscreener
9.86
1.69%
-0.17
Dopo l'orario di chiusura:
9.86
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PRTA Giù?
Forum
Previsione
Prothena Corporation Plc Borsa (PRTA) Ultime notizie
Analyst Calls: How do insiders feel about Prothena Corporation plc2026 Chart Watch & Daily Entry Point Alerts - baoquankhu1.vn
Gap Down: Can Prothena Corporation plc be recession proofWeekly Trend Report & AI Driven Price Predictions - baoquankhu1.vn
Prothena Corp plc Stock: Clinical Milestones and Strategic Focus in Biotechnology Drive Investor Int - AD HOC NEWS
PRTA Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
PRTA Technical Analysis & Stock Price Forecast - Intellectia AI
Understanding Momentum Shifts in (PRTA) - Stock Traders Daily
Top Growth Companies With High Insider Ownership In March 2026 - simplywall.st
JPMorgan Chase & Co. Buys 608,814 Shares of Prothena Corporation plc $PRTA - MarketBeat
Aug Patterns: Will Prothena Corporation plc outperform its industry peersWeekly Investment Report & Smart Investment Allocation Insights - baoquankhu1.vn
Stock Recap: Will Prothena Corporation plc benefit from rising consumer demandQuarterly Market Review & Weekly Hot Stock Watchlists - baoquankhu1.vn
Gainers Report: Will Prothena Corporation plc outperform tech stocks2026 Support & Resistance & Detailed Earnings Play Strategies - baoquankhu1.vn
Prothena (NASDAQ: PRTA) details 2026 AGM, pay and 2025 pipeline shifts - Stock Titan
When Can We Expect A Profit From Prothena Corporation plc (NASDAQ:PRTA)? - simplywall.st
Prothena Corporation plc (NASDAQ:PRTA) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Prothena Q4 earnings meet estimates, pipeline progress in focus - MSN
Published on: 2026-03-27 01:04:54 - baoquankhu1.vn
Wall Street Analysts Think Prothena (PRTA) Could Surge 120.19%: Read This Before Placing a Bet - sharewise.com
Dow Update: Will Prothena Corporation plc benefit from rising consumer demandEntry Point & Low Risk High Reward Trade Ideas - baoquankhu1.vn
H.C. Wainwright reiterates Prothena stock rating on Parkinson’s data By Investing.com - Investing.com UK
Prothena (NASDAQ:PRTA) Shares Cross Below Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Prothena Corp plc stock gains spotlight as partners Roche and Bristol-Myers Squibb showcase key clin - AD HOC NEWS
Prothena Partners Present Data Supporting Next Generation Treatme - The National Law Review
Prothena Partners Present Data Supporting Next Generation Treatments for Parkinson’s and Alzheimer’s Disease at AD/PD™ 2026 - Business Wire
Prothena Corp plc stock faces pressure amid biotech volatility and pipeline updates - AD HOC NEWS
Prothena authorizes up to $100 million share repurchase plan - MSN
Avoiding Lag: Real-Time Signals in (PRTA) Movement - Stock Traders Daily
History Review: Is Prothena Corporation plc attractive for institutional investors2026 Volume Leaders & Fast Momentum Stock Entry Tips - baoquankhu1.vn
Prothena Corp plc Stock (ISIN: IE00B91XRN20) Faces Biotech Headwinds Amid Pipeline Delays - AD HOC NEWS
Prothena Corp plc Stock (ISIN: IE00B91XRN20) Faces Headwinds Amid Biotech Volatility - AD HOC NEWS
Prothena Corporation plc $PRTA Stake Lessened by Prosight Management LP - MarketBeat
Prothena Corp plc Stock (ISIN: IE00B91XRN20) Under Pressure Amid Biotech Volatility - AD HOC NEWS
Citizens reaffirms Prothena stock rating on Novo Nordisk milestone By Investing.com - Investing.com South Africa
Prothena Corp plc Stock (ISIN: IE00B91XRN20) Faces Pressure Amid Biotech Volatility - AD HOC NEWS
Prothena earns $50M milestone from Novo Nordisk for drug trial - Investing.com Nigeria
IPO Launch: Will Prothena Corporation plc outperform tech stocks2026 Movers & Weekly High Return Forecasts - baoquankhu1.vn
Prothena (NASDAQ:PRTA) Share Price Passes Above 50-Day Moving AverageTime to Sell? - MarketBeat
Discipline and Rules-Based Execution in PRTA Response - Stock Traders Daily
Prothena Announces Achievement of $50 Million Clinical Milestone Payment from Novo Nordisk Related t - PharmiWeb.com
Prothena Announces Achievement of $50 Million Clinical Milestone Payment from Novo Nordisk Related to Ongoing Phase 3 Clinical Trial for Coramitug (Formerly PRX004) in ATTR Amyloidosis with Cardiomyopathy - The Joplin Globe
Prothena Corporation Plc Receives $50 Million Clinical Milestone Payment From Novo Nordisk - marketscreener.com
PRTA Earnings History & Surprises | EPS & Revenue Results | PROTHENA CORP PLC (NASDAQ:PRTA) - ChartMill
Is Prothena Corporation plc stock a dividend growth opportunity2025 Buyback Activity & Real-Time Buy Zone Alerts - Naître et grandir
Aug Reactions: Is Prothena Corporation plc attractive for institutional investors - baoquankhu1.vn
Prothena: A Hold With 2 Late-Stage Programs Underway But With Caution (NASDAQ:PRTA) - Seeking Alpha
Wall Street Analysts Believe Prothena (PRTA) Could Rally 118.09%: Here's is How to Trade - Finviz
Prothena (NASDAQ:PRTA) Shares Up 8.7%Still a Buy? - MarketBeat
Prothena Corporation plc (NASDAQ:PRTA) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Prothena Corporation plc (NASDAQ:PRTA) Given Average Recommendation of “Hold” by Analysts - Defense World
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):